
Please try another search
ADC Therapeutics SA (ADCT) reported Q1 EPS of ($0.36), $0.34 better than the analyst estimate of ($0.70). Revenue for the quarter came in at $46.5 million versus the consensus estimate of $28.94...
By Ludwig Burger and John Miller FRANKFURT/ZURICH (Reuters) - Dozens of drugmakers are conducting human trials for a record 89 therapies that pair antibodies with toxic agents to fight cancer,...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review